Discontinued — last reported Q2 '25
Business Segments · R&D
Life Science Member — R&D
STERIS Life Science Member — R&D increased by 9.1% to $2.40M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.1%, from $2.20M to $2.40M.
Analysis
StatementSegment
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ2 2022
Last reportedQ2 2025
Rolls up toR&D
How to read this metric
Higher spending suggests a focus on long-term product innovation and competitive differentiation, while lower spending may signal a focus on short-term profitability.
Detailed definition
This represents the investment in innovation, product development, and engineering specifically allocated to the Life Sc...
Peer comparison
Comparable to R&D expenditure metrics for business units focused on high-tech medical or industrial equipment.
Metric ID:
ste_segment_life_science_member_research_and_developmentHistorical Data
10 periods
| Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q2 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.85M | $1.85M | $1.85M | $1.85M | $2.06M | $2.06M | $2.06M | $2.06M | $2.20M | $2.40M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +11.4% | +0.0% | +0.0% | +0.0% | +6.6% | +9.1% |
| YoY Change | — | — | — | — | +11.4% | +11.4% | +11.4% | +11.4% | +6.6% | +9.1% |
Range$1.85M – $2.40M
CAGR+12.2%
Avg YoY Growth+10.2%
Median YoY Growth+11.4%
Current Streak9+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is STERIS's life science member — r&d?
- STERIS (STE) reported life science member — r&d of $2.40M in Q2 2025.
- How has STERIS's life science member — r&d changed year-over-year?
- STERIS's life science member — r&d increased by 9.1% year-over-year, from $2.20M to $2.40M.
- What does life science member — r&d mean?
- Spending on research and development activities for the Life Science segment.